PELP1 is dysregulated in 80–95% of PCa cases, especially in advanced and castration-resistant disease, associated with shorter survival rate and enrichment of pathways related to PCa progression, endocrine resistance, and hormone signaling [102,103]. Here, PELP1 is linked to posterior cortical atrophy.